Literature DB >> 33501462

Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays.

David Alland1, Padmapriya Banada1, Sukalyani Banik1, Kaheerman Saibire1, Shraddha Suryavanshi1, Glenn Johns2, Soumitesh Chakravorty2, Robert Kwiatkowski2.   

Abstract

BACKGROUND: Upper respiratory samples used to test for SARS-CoV-2 virus may be infectious and present a hazard during transport and testing. A buffer with the ability to inactivate SARS-CoV-2 at the time of sample collection could simplify and expand testing for COVID-19 to non-conventional settings.
METHODS: We evaluated a guanidium thiocyanate-based buffer, eNAT™ (Copan) as a possible transport and inactivation medium for downstream RT-PCR testing to detect SARS-CoV-2. Inactivation of SARS-CoV-2 USA-WA1/2020 in eNAT and in diluted saliva was studied at different incubation times. The stability of viral RNA in eNAT was also evaluated for up to 7 days at room temperature (28°C), refrigerated conditions (4°C) and at 35°C.
RESULTS: SARS-COV-2 virus spiked directly in eNAT could be inactivated at >5.6 log 10 PFU/ml within a minute of incubation. When saliva was diluted 1:1 in eNAT, no cytopathic effect (CPE) on vero-E6 cell lines was observed, although SARS-CoV-2 RNA could be detected even after 30 min incubation and after two cell culture passages. A 1:2 (saliva:eNAT) dilution abrogated both CPE and detectable viral RNA after as little as 5 min incubation in eNAT. SARS-CoV-2 RNA from virus spiked at 5X the limit of detection remained positive up to 7 days of incubation in all tested conditions.
CONCLUSION: eNAT and similar guanidinium thiocyanate-based media may be of value for transport, preservation, and processing of clinical samples for RT-PCR based SARS-CoV-2 detection.

Entities:  

Year:  2021        PMID: 33501462      PMCID: PMC7836134          DOI: 10.1101/2021.01.15.21249891

Source DB:  PubMed          Journal:  medRxiv


  17 in total

1.  Viral concentration determination through plaque assays: using traditional and novel overlay systems.

Authors:  Alan Baer; Kylene Kehn-Hall
Journal:  J Vis Exp       Date:  2014-11-04       Impact factor: 1.355

2.  VIRAL TRANSPORTATION IN COVID-19 PANDEMIC: INACTIVATED VIRUS TRANSPORTATION SHOULD BE IMPLEMENTED FOR SAFE TRANSPORTATION AND HANDLING AT DIAGNOSTICS LABORATORIES.

Authors:  Rajan Dewar; David Baunoch; Kirk Wojno; Vinita Parkash; Roya Khosravi-Far
Journal:  Arch Pathol Lab Med       Date:  2020-04-16       Impact factor: 5.534

3.  Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.

Authors:  Michael J Loeffelholz; David Alland; Susan M Butler-Wu; Utsav Pandey; Carlo Frederico Perno; Alice Nava; Karen C Carroll; Heba Mostafa; Emma Davies; Ashley McEwan; Jennifer L Rakeman; Randal C Fowler; Jean-Michel Pawlotsky; Slim Fourati; Sukalyani Banik; Padmapriya P Banada; Shobha Swaminathan; Soumitesh Chakravorty; Robert W Kwiatkowski; Victor C Chu; JoAnn Kop; Rajiv Gaur; Mandy L Y Sin; Duy Nguyen; Simranjit Singh; Na Zhang; David H Persing
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

4.  Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.

Authors:  Jennifer Harcourt; Azaibi Tamin; Xiaoyan Lu; Shifaq Kamili; Senthil K Sakthivel; Janna Murray; Krista Queen; Ying Tao; Clinton R Paden; Jing Zhang; Yan Li; Anna Uehara; Haibin Wang; Cynthia Goldsmith; Hannah A Bullock; Lijuan Wang; Brett Whitaker; Brian Lynch; Rashi Gautam; Craig Schindewolf; Kumari G Lokugamage; Dionna Scharton; Jessica A Plante; Divya Mirchandani; Steven G Widen; Krishna Narayanan; Shinji Makino; Thomas G Ksiazek; Kenneth S Plante; Scott C Weaver; Stephen Lindstrom; Suxiang Tong; Vineet D Menachery; Natalie J Thornburg
Journal:  Emerg Infect Dis       Date:  2020-06-17       Impact factor: 6.883

5.  Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?

Authors:  Boris Pastorino; Franck Touret; Magali Gilles; Xavier de Lamballerie; Remi N Charrel
Journal:  Viruses       Date:  2020-07-07       Impact factor: 5.048

6.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

7.  Corrigendum to "World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)" [Int. J. Surg. 76 (2020) 71-76].

Authors:  Catrin Sohrabi; Zaid Alsafi; Niamh O'Neill; Mehdi Khan; Ahmed Kerwan; Ahmed Al-Jabir; Christos Iosifidis; Riaz Agha
Journal:  Int J Surg       Date:  2020-04-15       Impact factor: 6.071

8.  Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.

Authors:  Praveen Kumar-M; Shubhra Mishra; Daya Krishna Jha; Jayendra Shukla; Arup Choudhury; Ritin Mohindra; Harshal S Mandavdhare; Usha Dutta; Vishal Sharma
Journal:  Hepatol Int       Date:  2020-07-04       Impact factor: 6.047

9.  Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing.

Authors:  David van Bockel; C Mee Ling Munier; Stuart Turville; Steven G Badman; Gregory Walker; Alberto Ospina Stella; Anupriya Aggarwal; Malinna Yeang; Anna Condylios; Anthony D Kelleher; Tanya L Applegate; Andrew Vallely; David Whiley; William Rawlinson; Phillip Cunningham; John Kaldor; Rebecca Guy
Journal:  Viruses       Date:  2020-10-23       Impact factor: 5.048

10.  Susceptibility of SARS-CoV-2 to UV irradiation.

Authors:  Christiane Silke Heilingloh; Ulrich Wilhelm Aufderhorst; Leonie Schipper; Ulf Dittmer; Oliver Witzke; Dongliang Yang; Xin Zheng; Kathrin Sutter; Mirko Trilling; Mira Alt; Eike Steinmann; Adalbert Krawczyk
Journal:  Am J Infect Control       Date:  2020-08-04       Impact factor: 2.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.